The results of CCK-8 (Fig. 5A), wound-healing (Fig. 5B) and transwell (Fig. 5C) assays indicated that ectopic Zeb1 expression promoted breast cancer cell viability and migration; however, treatment with the LDHA inhibitor OXM significantly weakened these effects. This evidence concerns the gene ZEB1 and breast cancer.